AFYON, M., ARTUK, C. (2015). Occult Hepatitis B Reactivation. Viral Hepatitis Journal, Cilt: 21 - Sayı: 3, 88–91. https://ajindex.com/articles/332708
References (6)
Uyanıkoglu A, Sert U, Nar H, Yenice N. Occult Hepatitis B Reactivation After Chemoteraphy: A Case Report. Viral Hepat J. 2015;21:56-58.
Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxi A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR, Zoulim F. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49:652-657. Said ZNA. An overview of occult hepatitis B virus infection. World J Gastroenterol. 2011;17:1927-1938.
Samal J, Kandpal M, Vivekanandan P. Molecular Mechanisms Underlying Occult Hepatitis B Virus Infection. Clin Microbiol Rev. 2012;25:142-163.
Raimondo G, Caccamo G, Filomia R, Pollicino T. Occult HBV infection. Semin Immunopatho. 2013;35:39-52. Zobeiri M. Occult hepatitis B: clinical viewpoint and management. Hepat Res Treat. 2013;2013:259148. Papamichalis P, Alexiou A, Boulbou M, Dalekos GN, Rigopoulou EI. Reactivation of resolved hepatitis B virus infection after immunosuppression: is it time to adopt preemptive therapy?. Clin Res Hepatol Gastroenterol. 2012;36:84-93.
Watanabe M, Shibuya A, Tsunoda Y, Danbara M, Ishii R, Ohsaka M, Takada J, Tanaka Y, Okuwaki Y, Minamino T, Hidaka H, Nakazawa T, Horie R, Higashihara M, Koizumi W. Re-appearance of hepatitis B virus following therapy with rituximab for lymphoma is not rare in Japanese patients with past hepatitis B virus infection. Liver Int. 2011;31:340-347.
Lledo JL, Fernandez C, Gutierrez ML, Ocana S. Management of occult hepatitis B virus infection: an update for the clinician. World J Gastroenterol. 2011;17:1563-1568.